Product Information
ZITUVIMET 50-500 MG TABLET is a brand product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $5.0717 per EA under NDC 70710178606. Its NADAC has been published 58 times since May 21, 2025.
Strength
500; 50 mg/1; mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710178606
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METFORMIN HYDROCHLORIDE; SITAGLIPTINApproval Type
New Drug (NDA)
FDA Application
NDA216743On Market Since
3/14/2024
Pharmacological Classes
Price Statistics
The NADAC for ZITUVIMET 50-500 MG TABLET has been published 58 times since May 21, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.0717 per EA |
|---|---|
| All-time high | $5.0779 (Jun 10, 2026) |
| All-time low | $5.0483 (May 21, 2025) |
| 52-week high | $5.0779 |
| 52-week low | $5.0483 |
| Median price | $5.0488 |
| Average price | $5.0554 |
| Largest weekly change | +0.3% (Mar 18, 2026) |
| Weeks tracked | 58 |
| Tracking since | May 21, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Sitagliptin and Metformin Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ZITUVIMET 50-500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZITUVIMET 50-500 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $5.0717 per EA (NDC 70710178606), effective Jun 24, 2026.
How has the price of ZITUVIMET 50-500 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZITUVIMET 50-500 MG TABLET has held within roughly two percent of its current level. It has been tracked across 58 weekly CMS publications since May 21, 2025.
What are the highest and lowest recorded NADAC prices for ZITUVIMET 50-500 MG TABLET?
Since May 21, 2025, the NADAC for ZITUVIMET 50-500 MG TABLET has ranged from a low of $5.0483 (May 21, 2025) to a high of $5.0779 (Jun 10, 2026), with a median of $5.0488 per EA.
Are there cheaper alternatives to ZITUVIMET 50-500 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ZITUVIMET 50-500 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ZITUVIMET 50-500 MG TABLET?
ZITUVIMET 50-500 MG TABLET (NDC 70710178606) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification